AUS
NZ
UK
CA
USA
IND
Highlights
Blue-chip stocks represent firms with robust fundamentals.
These companies have strong cash flows.
Blue-chip shares are also known to perform on a decent note during challenging times.
Blue-chip stocks generally remain the first preference of the majority of investors on account of their strong fundamentals. These represent companies which have robust business models, stable cash flows and extensive operations. These stocks are also lapped by investors due to their track record of performing much better than peers during uncertain times.
Here, we discuss five blue-chip stocks with over 4% returns in the past year:
Domino’s Pizza Enterprises Ltd (ASX:DMP)
ASX-listed Domino’s Pizza Enterprises is Australia’s largest pizza chain on the basis of stores and sales. In the past five days, shares of Domino’s Pizza Enterprises have given returns of 10.36%, as of 12:06 AM (AEST), Tuesday. However, the share price has fallen 1.28% in the past month. In one of its latest presentations, the AU$6.02-billion company highlighted its performance during the last two years of the COVID-19 pandemic. During the period, Domino’s network sales surged 29.5% and earnings before interest and tax (EBIT) rose 25.2%.
RELATED ARTICLE: RMD, CPU, BXB, AMC: How these ASX blue chips have fared in last five days
Goodman Group (ASX:GMG)
Goodman Group is an ASX-listed integrated industrial and commercial property group. In the past five days, shares of Goodman Group have given returns of 6.49%, as of 12:06 AM (AEST), Tuesday. However, the share price has fallen 7.36% in the past month. The AU$35.23-billion firm’s shares are scheduled to trade ex-dividend on 29 June 2022. It would be paying 15 cents per stapled security dividend to its shareholders.
ResMed Inc (ASX:RMD)
ResMed is a medical device company which is based out of California, the US. In the past five days, shares of ResMed have given returns of 5.70%, as of 12:06 AM (AEST), Tuesday. However, the share price has risen 4.76% in the past month. The ASX-listed AU$45.07-billion sleep treatment firm recently announced the acquisition of Medifox Dan for US$1 billion.
RELATED ARTICLE: ALL, S32, COL: How these ASX blue-chip stocks have fared in 2022 so far
Cochlear Ltd (ASX:COH)
Cochlear is a healthcare company which provides a wide range of implantable hearing solutions. In the past five days, shares of Cochlear have given returns of 5.61%, as of 12:06 AM (AEST), Tuesday. However, the share price has fallen 10% in the past month. In its half-year results for FY22, the AU$13.34-billion company’s cochlear implant business reported a 12% rise in sales revenue in terms of constant currency.
CSL Ltd (ASX:CSL)
CSL is an Australia-based specialty biotechnology company which operates across the globe. In the past five days, shares of CSL have given returns of 4.66%, as of 12:06 AM (AEST), Tuesday. However, the share price has fallen 0.27% in the past month. The AU$131.50-billion company recently said that its Vifor Pharma acquisition deal was expected to get delayed by a few more months due to a delay in receiving the regulatory nod.
